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The enzymatic activity of rabbit skeletal-muscle 
glycogen phosphorylase is regulated by several mecha- 
nisms. Allosteric transitions and the degree of associa- 
tion of phosphorylase monomers are key factors in 
control. These regulatory characteristics are affected 
by whether the amino-terminal region of phosphorylase 
is phosphorylated or dephosphorylated. The mecha- 
nism by which the phosphorylatable amino-terminal 
region affects catalytic, allosteric, and association 
properties has not been elucidated. Some information 
may be obtained by studying how regulatory properties 
are affected when the amino-terminal region interacts 
with a probe that reacts specifically with the amino- 
terminal region. An antibody specific for the amino- 
terminal region could be a suitable probe for such 
studies. Antibodies have been utilized for exploring 
the cqnformations of many protein molecules; this 
topic has been reviewed recently by Anfinsen and 
Scheraga [l] . Preparation of antibodies against 
fragments of protein molecules has been performed 
previously [2-51 . When it is desirable to have anti- 
bodies to a conformation of the protein fragment 
possessed by the intact native protein, the native 
protein is used as the antigen in preparing the anti- 
bodies: The antibodies specific for the given protein 
fragment are isolated by affinity chromatography on 
a resin that contains covalently bound protein frag- 
ments. We have applied this general procedure for the 
isolation of antibodies specific for the amino-terminal 
region of phosphorylase. Evidence is presented for 
the specificity of the isolated antibody population, 
and the use of this antibody population in studying 
phosphorylase is briefly described. 
2. Experimental 
2.1. Antibody preparation 
A young female goat was inoculated with 20 mg 
phosphorylase a in 2 ml 0.15 M NaCl, 0.05 M glucose, 
1 mM TrisCl, pH 7.4, emulsified with 2 ml complete 
adjuvant. After 2 weeks, the goat was boosted with 
40 mg of phosphorylase a in the same buffer, but 
without adjuvant. Two weeks later, an identical 
booster injection was performed. After 1 week, a 
500 ml blood sample was obtained; experiments 
described in this paper were performed by using anti- 
body isolated from this blood sample. Antibody 
against goat serum was prepared by immunizing New 
Zealand white rabbits with goat serum emulsified 
with complete adjuvant. The y-globulin fractions of 
goat antisera (goat y-globulin) and rabbit antisera 
(rabbit anti-goat y-globulin) were prepared by precipi- 
tation in the presence of 35% saturated ammonium 
sulfate. The y-globulin precipitate was dissolved in 
water, dialyzed against 0.15 M NaCl and stored at 
-20°C. Measurement of protein in solutions containing 
immunoglobulins was performed by the method of 
Lowry et al. [6]. 
2.2. Affiniw chromatography resin 
Procedures used in affinity chromatography have 
been modified from those described by Young et al. 
[2]. A peptide, (l-18)p, corresponding to the last 
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18 amino-terminal residues of phosphorylase a, was 
synthesized, phosphorylated, purified, and was 
found to be homogeneous by methods that have 
been described previously [7] . The amino acid 
sequence of (l-l 8)p is NH2 SerArgProLeuSerAspGln- 
GluLysArgLysGlnIleSer(P04)ValArgGlyLeuC00H. 
Sepharose 4B (Pharmacia) that had been activated 
with cyanogen bromide [8] was reacted with (1-18)~ 
in 0.1 M sodium bicarbonate, pH 7.4. The resulting 
affinity resin contained 0.35 pmol (l-18)p/ml. 
2.3. Glycogen phosphorylases 
Rabbit skeletal-muscle glycogen phosphorylase b 
was isolated as by Fischer and Krebs [9] , and phos- 
phorylase a was prepared from phosphorylase b by 
phosphorylation with rabbit-muscle phosphorylase 
kinase [lo] . Phosphorylase b’ was obtained from 
phosphorylase a by limited proteolysis with trypsin 
[ 1 l] . Phosphorylase activity was measured in the 
direction of glycogen synthesis either by the method 
of Engers et al. [ 121 or by incorporation of [‘“Cl 
glucose from [ 14C] glucose 1 -phosphate into glycogen 
as described by Parrish and Graves [ 131 . The protein 
concentration of phosphorylase was measured spectro- 
photometrically by using the extinction coefficient 
E:fmm at 280 nm of 13.2 [ 141 . A phosphorylase 
monomer was assumed to be mol. wt 100 000 [ 151. 
2.4. 3H-Labelled antigens 
Phosphorylases a, b, and b’ were tritiated by a 
limited reaction with [3H]acetic anhydride (New 
England Nuclear, 400 mCi/mmol). Less than 5% 
of the total lysine and tryosine residues were 
acetylated per monomer, and greater than 70% of 
the enzymatic activity was recovered. An acetylated 
phosphopeptide, Ac(l-18)p, and an acetylated 
dephosphopeptide, Ac(l-18), were prepared accord- 
ing to procedures previously described [7] . The 
amino terminus of native phosphorylase is N-acetyl- 
ated. The amino acid sequence of Ac(l-18)~ is the 
same as (l-l 8)p except that the amino terminus is 
N-acetylated, and Ac(l-18) differs from Ac(l-18)~ 
in that serine-14 is not phosphorylated. The amino 
termini of these peptides were acetylated with acetic 
anhydride; other reactive functional groups were 
chemically blocked. [3H]Acetic anhydride was used 
when radioactive peptides were prepared. 
2.5. Radioimmunoassays 
The double antibody radioimmunoassay consisted 
of three steps: 
(i) Incubation of antibody with 3H-labelled antigens. 
(ii) Incubation with rabbit anti-goat y-globulin (a 
wide range of rabbit anti-goat y-globulin concen- 
trations gave maximal precipitation of goat 
y-globulin). 
(iii) Incubation with normal goat y-globulin, isolated 
from a goat that had not been immunized, to 
increase the quantity of precipitate. 
Precipitates were pelleted by centrifugation and washed 
twice with 0.5 ml 1.6 mg/ml bovine serum albumin 
(Pentex crystalline) in 0.15 M NaCl, and 20 mM TrisCI, 
pH 7.4. The washed precipitates were dissolved in 
100 fi 0.25 M NaOH and then assayed for radioactivity. 
All radioimmunoassay data have been corrected for 
controls in which antibody was not present. 
3. Results 
Immune goat y-globulin was fractionated by 
affinity chromatography (fig.1). The affinity resin 
consisted of a peptide, corresponding to the last 
18 amino-terminal residues of phosphorylase a, 
covalently attached to Sepharose 4B. Of the 270 mg 
y-globulin applied to the column, only 0.6% was 
adsorbed by the column. The adsorbed protein was 
1 
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Fig.1. Elution profile of immune goat y-globulin from 
Sepharose-(1-18)~. To 1.0 ml Sepharose-(1-18)~ equili- 
brated in column buffer (0.15 M NaCI, 0.01 M KH,PO,, 
0.01 M Na,HPO,, pH 7.3), 270 mg goat r-globulin in 5.0 ml 
column buffer was applied. The column was washed with 
column buffer until the A 280 of the effluent was no longer 
decreasing. The bound material was eluted by treatment with 
4 M guanidine.HCl (arrow). 
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eluted with 4 M guanidine.HCI and immediately 
dialyzed against 0.15 M NaCl. Of the antibody 
activity against phosphorylase a that was applied to 
the column, only 2.4% was contained in the guanidine. 
HCl eluate. The recovery of antibody activity against 
Ac(l-18)~ in the guanidine.HCl eluate is not known 
because this activity was not detectable in the 
y-globulin fraction applied to the column. Measure- 
ment of antibody activity against Ac(l-18)~ in the 
y-globulin fraction was apparently inhibited by the 
high concentration of protein in this fraction. When 
the guanidine.HCl fraction was mixed with the 
y-globulin fraction, antibody activity against 
Ac(l-18)p, originally present in the guanidine.HCl 
fraction, was not detectable. The guanidine.HCl 
fraction, anti-(1 - 18)p, was stored in 0.5 ml portions 
in the freezer. No loss in immunological activity 
towards either phosphorylase a or peptide antigens 
was observed after at least 3 months storage. 
The specificity of anti-(1 -18)~ was analyzed by 
radioimmunoassay. When anti-(1 -18)~ was reacted 
with either phosphorylase or peptide antigens, soluble 
complexes were formed. Thus, it was necessary to 
introduce a second antibody, produced in rabbit 
against goat serum, to precipitate the complexes 
formed by anti-(1 -18)~ with these antigens. The 
specificity of anti-(1 -1 S)p for [3H] phosphorylase 
and [3H] peptide antigens is presented in table 1. 
Phosphorylase a was a much better antigen than 
phosphorylase b. Phosphorylase b’, a derivative of 
phosphorylase a in which the last 16 amino-terminal 
residues have been removed, is a very poor antigen. 
The small amount of radioactivity found in the 
precipitate from the phosphorylase b’ radioimmuno- 
assay could be accounted for by contaminating phos- 
phorylase a, which amounted to 6% for the phos- 
phorylase b’ preparation. This observation suggests 
that the amino-terminal region is necessary for inter- 
action of phosphorylase with anti-(l-18)~. The 
phospho-amino-terminal peptide, Ac(l-18)p, and the 
dephospho-amino-terminal peptide, Ac( l-1 8), served 
equally well as antigens. Therefore, the phosphate 
group is not necessary for antibody interaction. 
The binding of [3H]phosphorylase a to anti- 
(l-l 8)p in the presence of different amounts of non- 
radioactive Ac(l-18)~ is plotted in fig.2. The inter- 
action of phosphorylase a with anti-(1 -18)~ would be 
inhibited by 50% if 1200 pmol Ac(l-18)~ were 
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Table 1 
Antibody specificity for phosphorylase antigens and 
peptide antigens 
Antigen Antigen in precipitate 
(%) 
Phosphorylase aa 61 
Phosphorylase ba 27 
Phosphorylase !r’ a 4.5 
Ac(l-18)pb 40 
Ac(l-18)b 42 
a Radioimmunoassay: The incubation mixture (455 ~1) 
contained 73 pmol (27 000-37 000 cpm) [‘Hlphosphoryl- 
ase, 27 pg anti-(1 -- 18)p, 0.8 mg bovine serum albumin, 
75 nmol NaCl, and 10 pmol TrisCl, pH 7.4. After incubation 
for 30 min at 37”C, 4.0 mg (50 ~1) rabbit anti-goat y-globulin 
was added. After 10 min at 37”C, 250 ng (5 ~1) normal 
goat y-globulin was added, and the mixture was incubated 
at 37°C for 30 min. Precipitates were washed and analyzed 
for radioactivity as described in the text 
b Radioimmun assay: The incubation mixture (455 ~1) 
contained 700 pmol (3000 cpm) [3H]peptide, 85 ng anti- 
(l-18)p, 75 prnol NaCl and 10 pmol TrisCl, pH 7.4. After 
incubation for 60 min at 37”C, 4.0 mg (50 ~1) rabbit anti- 
goat y-globulin was added. After 30 min at 37°C and 1 day 
at 4”C, 250 pg (5 ~1) normal goat r-globulin was added and 
the mixture was incubated at 37°C for 30 min and at 4°C 
for 1 day. Precipitates were washed and analyzed for radio- 
activity as described in the text 
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Fig.2. Inhibition of phosphorylase a binding to anti-(1 - 18)p 
by non-radioactive Ac(l-18)~. [‘H]Phosphorylasea (74 
pmol, 38 000 cpm) was incubated with different amounts 
of Ac(l-lS)p, 11 c(g anti-(1-18)p, 0.8 mg bovine serum 
albumin, 75 nmol NaCl and 10 nmol TrisCl, pH 7.4, in total 
vol. 45.5 pl. After 30 min at 37”C, 4.0 mg (50 ~1) rabbit 
anti-goat y-globulin was added. After 10 min at 37”C, 
250 ng (5 ~1) normal goat y-globulin was added and the 
mixture was incubated at 37°C for 30 min. Precipitates were 
washed and analyzed for radioactivity as described in the 
text. 
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Fig.3. Inhibition of Ac(l-18)~ binding to anti-(1-18)~ by 
phosphorylase a. [aH]-Ac(l-18)~ (700 pmoles, 3000 cpm) 
was incubated with different amounts of phosphorylase a, 
33 Hg anti-(l-18)p, 75 pmol NaCl and 10 pmol TrisCl, 
pH 7.4, in total vol. 455 ~1. After 60 min at 3O”C, 1.6 mg 
(20 ~1) rabbit anti-goat -y-globulin was added. After 30 min 
at 30°C and 1 day at 4°C 250 pg (5 ~1) normal goat 
-r-globulin was added and the mixture was incubated at 30°C 
for 30 min. Precipitates were washed and analyzed for radio- 
activity as described in the text. 
present; 74 pmol [3H] phosphorylase a were present 
in the assays. Therefore, under the conditions of the 
radioimmunoassay, phosphorylase a can compete more 
effectively than Ac(l-18)~ for anti-(1-18)~. At the 
highest concentration of Ac(l-18)~ tested, phospho- 
rylase a binding to anti-( 1 - 18)~ was inhibited by 
97%. 
The binding of [3H] -Ac(l-18)~ to anti-(1-18)p 
in the presence of different amounts of non-radio- 
active phosphorylase a is represented by fig.3. Binding 
of [3H]Ac(l-18)p to anti-(1-18)~ was inhibited by 
93% at the highest concentration of phosphorylase a 
tested. In other experiments, not described in this 
paper, phosphorylase b was able to cause nearly 
complete inhibition of the interaction of Ac(l-18)~ 
with anti-(1-18)p, whereas phosphorylase b’ was not 
an inhibitor. These results provide strong evidence 
that the antibodies against phosphorylase a in the 
anti-( l-l 8)p fraction are specific for determinants 
located within the last 18 amino-terminal residues of 
the enzyme. 
Because of the importance of the phosphorylated 
amino-terminal region in affecting catalytic properties 
of phosphorylase a, the effect of anti-(1 -18)~ on 
enzymatic activity of phosphorylase a and b’ was 
measured (table 2). Phosphorylase a normally is active 
with or without 5’-AMP present. Interaction of anti- 
Table 2 
Antibody inhibition of phosphorylase enzymatic activitya 
- 
Phosphorylase Anti-( 1- 18)~ Inhibition (%) 
kg) 
S-AMP S-AMP 
absent present 
a 
a 
b’ 
16 40 6.1 
33 62 23 
33 _ 5.7 
a Phosphorylase (0.35 pg) was pre-incubated with anti- 
(1-18)~ in 0.04 M P-glycerophosphate, 0.03 M 2-mercapto- 
ethanol, 0.06 M NaCl, pH 6.8, in total vol. 50 ~1. After 
30 min at 30°C, an aliquot was removed and assayed for 
enzymatic activity in the presence and absence of 1 mM 
5’-AMP by using the [?]gIucose l-phosphate assay 
described by Parrish and Graves [ 131. Inhibition was 
measured relative to experiments in which normal goat 
r-globulin was present in place of anti-(1 -18)~ 
(1- 18)~ with phosphorylase a inhibits catalytic 
activity measured in the absence of 5’-AMP much more 
than catalytic activity measured in the presence of 
5’-AMP. The presence of l-l 0 mM 5’-AMP during 
pre-incubation of anti-(1-18)~ with phosphorylase a 
had no effect on the interaction of anti-(1 -18)~ with 
phosphorylase CI. Therefore, it is unlikely that the 
greater activity when assayed in the presence of 5’- 
AMP can be explained by disruption by 5’-AMP of 
the interaction of anti-( l-l 8)p with phosphorylase a. 
The catalytic activity of phosphorylase b’, which is 
dependent on the presence of 5’-AMP for activity, 
was only slightly inhibited. Contaminating phospho- 
rylase a in the phosphorylase b’ preparation could 
account for Lhis inhibition. 
4. Discussion 
A peptide, (l-l 8)p, corresponding to the last 
18 amino-terminal residues of glycogen phosphorylase 
a, was covalently linked to Sepharose 4B. Antibodies, 
anti-(1-18)p, that are bound to and eluted from a 
column of this affinity resin react specifically with 
determinants contained within the last 18 amino- 
terminal residues of phosphorylase. The evidence 
presented supporting this conclusion is: 
(1) The amino-terminal phosphopeptide, Ac(l-18)p, 
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(2) 
(3) 
could essentially completely inhibit the inter- 
action of anti-(1 -18)~ with phosphorylase a. 
Phosphorylase cz could cause nearly complete 
inhibition of the interaction of Ac(l-18)~ with 
anti-(1-18)~. 
Phosphorylase b’, which is missing the last 16 
amino-terminal residues of native phosphorylase, 
did not have significant interaction with anti- 
(1-18)~ and could not inhibit the interaction of 
Ac(l-18)~ with anti-(l-18)~. 
The isolated anti-(1 -18)~ fraction had more 
immunoreactivity with phosphorylase a than with 
phosphorylase b; however, phosphopeptide, 
Ac(l-18)p, and dephosphopeptide, Ac(l-18)p, were 
about equal as antigens. Therefore, the greater 
immunoreactivity of phosphorylase a relative to 
phosphorylase b is not because the phosphate group 
is directly involved in the antibody interaction. The 
difference probably is due to conformational changes 
in the protein induced by phosphorylation of the 
amino-terminal region. Phosphorylase a competes 
more effectively for anti-(1 -18)~ than does 
Ac(l-18)~. Thus, Ac(l-18)~ may lack the conforma- 
tional integrity or part of the antigenic determinant(s) 
possessed by phosphorylase CI. Further speculation 
regarding the meaning of these observations cannot 
be made until the specificity of the anti-( l-1 8)p 
fraction has been characterized in greater detail. 
Studies are being conducted in this laboratory to 
determine how much of the amino-terminal region 
and which amino-acid residues are necessary for 
complexation with anti-(1 -18)~. 
When phosphorylase a was pre-incubated with 
anti-(l-l 8) catalytic activity of the enzyme in the 
absence of 5’-AMP was inhibited much more than 
catalytic activity measured in the presence of 5’-AMP. 
Activity in the presence of 5’-AMP is not dependent 
on whether the amino-terminal region is phosphoryl- 
ated. Therefore, the antibody is able specifically to 
interfere with the functioning of the phosphorylated 
amino-terminal region in activating phosphorylase, 
without greatly interfering with the catalytic process. 
A more detailed analysis of the effect of anti-(1 -18)~ 
on the conformation and the regulatory properties of 
phosphorylase a may provide information that will 
help explain how the phosphorylated amino-terminal 
region is involved in activating phosphorylase in the 
absence of 5’-AMP. 
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